4.6 Editorial Material

MeCP2 as an Activator of Gene Expression

Journal

TRENDS IN NEUROSCIENCES
Volume 41, Issue 2, Pages 72-74

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tins.2017.11.005

Keywords

-

Categories

Funding

  1. National Institutes of Health [MH070727]
  2. Division of Basic Sciences Training Program National Institutes of Health at UT Southwestern Medical Center [T32 GM008203]

Ask authors/readers for more resources

Rett syndrome is a neurodevelopmental disorder that primarily affects females and is caused by mutations in the methyl-CpG-binding-protein 2 (MECP2) gene. Initially, MeCP2 had been shown to be a repressor of gene transcription. In their 2008 paper, Chahrour and colleagues (DOI: 10.1126/science.1153252) reported that MeCP2 could also function as a transcriptional activator.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available